Trending
- FDA expert panel endorses Grail’s Galleri multi-cancer blood test
- Gloucester blood cancer patient praises free counselling service
- SETDB1 cooperates with the CRL4B complex to promote colorectal cancer tumorigenesis by disrupting circadian rhythm
- Subcutaneous Pembrolizumab Approved in Japan for All Tumor Indications
- FDA MCGP Panel Votes in Favor of the Galleri Multicancer Early Detection Test
- FDA Grants Approval to Lirafugratinib for Advanced Cholangiocarcinoma with FGFR2 Alteration
- Sarah Fisher, animal welfare advocate, died of thyroid cancer – inquest
- Approaching Cardiovascular Risk in Prostate Cancer Hormonal Therapy
Thursday, September 24